(607) 227-8695info@prendismo.com

Richard Ramko Discusses M&A Activity Among Biotech Firms In 2005

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 4/4/2006
  • Clip Duration : 0 min. 23 sec.

Playlists

Please Login to create playlists

Richard Ramko

  • Partner, Ernst & Young
  • male
  • Caucasian
  • 1966 (Age: 58 years old)
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • Video 1 of 11 in this Case
  • View All Available Videos

Biography

Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.

Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.

M&A activity was also up in 2005 with 205 deals completed compared to the 159 deals in 2004. Large pharmaceutical and biotechnology companies acquired products, expertise, and interestingly vaccine development and production infrastructure.(00:56:09) The largest deals focused on marketed or late st...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

Richard Ramko videos

Video 1 of 11 Richard Ramko Provides Brief Overview of Global Biotechnology Industry
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 3 min. 3 sec.
Video 2 of 11 Richard Ramko Discusses The Merck Biotech Index
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 51 sec.
Video 3 of 11 Richard Ramko Discusses Financing Within The Biotech Sector
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 1 min. 22 sec.
Video 4 of 11 Richard Ramko Discusses Biotech Stock Performance In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 3 min. 53 sec.
Video 5 of 11 Richard Ramko Discusses Trend In Corporate Alliances Among Biotech Companies In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 1 min. 43 sec.
Video 6 of 11 Richard Ramko Discusses M&A Activity Among Biotech Firms In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 23 sec.
Video 7 of 11 Richard Ramko Discusses R&D Expenditures In Biotech Industry In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 1 min. 33 sec.
Video 8 of 11 Richard Ramko States Losses In Biotech Sector Have Decreased
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 27 sec.
Video 9 of 11 Richard Ramko States Product Approval In Biotech Is Increasing
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 50 sec.
Video 10 of 11 Richard Ramko Shares Thoughts On Biotech Firms Choosing To Go Public
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 1 min. 2 sec.
Video 11 of 11 Richard Ramko Shares Reasoning For Increasing Alliances Within Biotech Sector
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 32 sec.

RELATED VIDEOS

Richard Ramko Provides Brief Overview of Global Biotechnology Industry
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 3 min. 3 sec.
Richard Ramko Discusses The Merck Biotech Index
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 51 sec.
Richard Ramko Discusses Financing Within The Biotech Sector
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 1 min. 22 sec.
Richard Ramko Discusses Biotech Stock Performance In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 3 min. 53 sec.
Richard Ramko Discusses M&A Activity Among Biotech Firms In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 23 sec.
Richard Ramko Discusses R&D Expenditures In Biotech Industry In 2005
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 1 min. 33 sec.
Richard Ramko States Losses In Biotech Sector Have Decreased
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 27 sec.
Richard Ramko States Product Approval In Biotech Is Increasing
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 50 sec.
Richard Ramko Shares Reasoning For Increasing Alliances Within Biotech Sector
  • Invention To Venture - April 2006 - Richard Ramko - Beyond Borders: Ernst & Young Life Science Report
  • 4/4/2006
  • Richard Ramko
  • 0 min. 32 sec.